Drug profile · INN
mestranol
NORETHIN 1/50M-21
mestranol (NORETHIN 1/50M-21) is a estrogen receptor alpha agonist. Route of administration: oral-21. Current US regulatory status: approved.
Drug details — mestranol
- US status
- approved
- Class
- —
- Route
- ORAL-21
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mestranol (NORETHIN 1/50M-21) is a estrogen receptor alpha agonist. Route of administration: oral-21. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mestranol?
mestranol (NORETHIN 1/50M-21) is a estrogen receptor alpha agonist. Route of administration: oral-21. Current US regulatory status: approved.
What is the brand name for mestranol?
NORETHIN 1/50M-21 is a marketed brand name for mestranol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mestranol?
mestranol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.